{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:52:50Z","timestamp":1776426770618,"version":"3.51.2"},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.6332","type":"journal-article","created":{"date-parts":[[2016,8,14]],"date-time":"2016-08-14T22:04:46Z","timestamp":1471212286000},"page":"2277-2280","source":"Crossref","is-referenced-by-count":15,"title":["Malignant Hypertension with Thrombotic Microangiopathy"],"prefix":"10.2169","volume":"55","author":[{"given":"Hayato","family":"Mitaka","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Tokyo Bay Urayasu Ichikawa Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Medicine, Mount Sinai Beth Israel, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Hamada","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Nerima Hikarigaoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Kosaka","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Nerima Hikarigaoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Nerima Hikarigaoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Miyakawa","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Nerima Hikarigaoka Hospital, Japan"},{"name":"Department of General Internal Medicine, Saitama Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med 371: 654-666, 2014.","DOI":"10.1056\/NEJMra1312353"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Cataland SR, Wu HM. How I treat: the clinical differentiation and initial treatment of adult patients with atypical hemolytic uremic syndrome. Blood 123: 2478-2484, 2014.","DOI":"10.1182\/blood-2013-11-516237"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Scully M, Goodship T. How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome. Br J Haematol 164: 759-766, 2014.","DOI":"10.1111\/bjh.12718"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Coppo P, Schwarzinger M, Buffet M, et al; French Reference Center for Thrombotic Microangiopathies. Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience. PLoS One 5: e10208, 2010.","DOI":"10.1371\/journal.pone.0010208"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. George JN. How I treat patients with thrombotic thrombocytopenic purpura. Blood 116: 4060-4069, 2010.","DOI":"10.1182\/blood-2010-07-271445"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Shibagaki Y, Fujita T. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)\/thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other? Hypertens Res 28: 89-95, 2005.","DOI":"10.1291\/hypres.28.89"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kato S, Tanaka M, Isonishi A, Matsumoto M, Samori T, Fujimura Y. A rapid, fully automated and highly sensitive ADAMTS13 gold particle immunoassay using a routine biochemistry analyser. Br J Haematol 171: 655-658, 2015.","DOI":"10.1111\/bjh.13425"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Khanal N, Dahal S, Upadhyay S, Bhatt VR, Bierman PJ. Differentiating malignant hypertension-induced thrombotic microangiopathy from thrombotic thrombocytopenic purpura. Ther Adv Hematol 6: 97-102, 2015.","DOI":"10.1177\/2040620715571076"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Brain MC, Dacie JV, Hourihane DO. Microangiopathic haemolytic anaemia: the possible role of vascular lesions in pathogenesis. Br J Haematol 8: 358-374, 1962.","DOI":"10.1111\/j.1365-2141.1962.tb06541.x"},{"key":"10","unstructured":"10. Khanna A, McCullough PA. Malignant hypertension presenting as hemolysis, thrombocytopenia, and renal failure. Rev Cardiovasc Med 4: 255-259, 2003."},{"key":"11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0140-6736(00)02539-3","volume":"356","author":"CJ Vaughan","year":"2000","unstructured":"11. Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet 356: 411-417, 2000.","journal-title":"The Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Patterson ME, Mouton CR, Mullins JJ, Mitchell KD. Interactive effects of superoxide anion and nitric oxide on blood pressure and renal hemodynamics in transgenic rats with inducible malignant hypertension. Am J Physiol Renal Physiol 289: F754-F759, 2005.","DOI":"10.1152\/ajprenal.00419.2004"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Cappellini MD. Coagulation in the pathophysiology of hemolytic anemias. Hematology Am Soc Hematol Educ Program 2007: 74-78, 2007.","DOI":"10.1182\/asheducation-2007.1.74"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Espinosa G, Bucciarelli S, Cervera R, et al. Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies. Ann Rheum Dis 63: 730-736, 2004.","DOI":"10.1136\/ard.2003.007245"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Akimoto T, Muto S, Ito C, et al. Clinical features of malignant hypertension with thrombotic microangiopathy. Clin Exp Hypertens 33: 77-83, 2011.","DOI":"10.3109\/10641963.2010.503303"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Thachil J. The malignant hypertension-thrombotic microangiopathy link. Hypertension 52: e32; author reply e33, 2008.","DOI":"10.1161\/HYPERTENSIONAHA.108.118679"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Alfishawy M, Babigumira M, Bashir T. Malignant hypertension and thrombotic thrombocytopenic purpura: False friends. Am J Case Rep 16: 374-376, 2015.","DOI":"10.12659\/AJCR.892787"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/16\/55_55.6332\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T14:57:08Z","timestamp":1568300228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/16\/55_55.6332\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":17,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.6332","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}